Pain Management Following Sinus Surgery
Nasal Sinus; Inflammation, Opioid Abuse, Pain, Postoperative
About this trial
This is an interventional treatment trial for Nasal Sinus; Inflammation focused on measuring NSAIDs, post-operative pain, post-operative hemorrhage, Functional endoscopic sinus surgery
Eligibility Criteria
Inclusion Criteria:
• All patients age 18-65 undergoing functional endoscopic sinus surgery +/- nasal airway surgery (septoplasty and/or inferior turbinate reduction).
Exclusion Criteria:
- Not taking anti-coagulation medications including aspirin
- Clinical Diagnosis of aspirin-exacerbated respiratory disease
- Clinical Diagnosis of Cystic Fibrosis
- Clinical Diagnosis of Primary Ciliary Dyskinesia
- Inclusion of a Draf III frontal sinusotomy
- Clinical Diagnosis of Liver/Kidney Failure
- Clinical Diagnosis of Thrombocytopenia
- Clinical Diagnosis of Poorly controlled hypertension
- Clinical Diagnosis of Recent GI ulcers or gastritis
- Clinical Diagnosis of Chronic pain as defined by a narcotic prescription with 6 months or involvement in a pain management program
- Clinical Diagnosis of Primary Headache disorder
- The use of nasal decongestants in the post-operative period.
- The use of nasal packing or absorbable biomaterials.
Sites / Locations
- University of Nebraska Medical Center
- University of Cincinnati
Arms of the Study
Arm 1
Arm 2
Other
Active Comparator
Standard Tylenol Regimen
Ibuprofen 600mg
Patient will be given a standard regimen: Tylenol 1000 mg by mouth every 6 hours scheduled and a rescue prescription of oxycodone 5 mg tablets by mouth every 6 hours as needed for pain. Ten total oxycodone tablets will be prescribed.
Tylenol 1000 mg by mouth every 6 hours scheduled and ibuprofen 600 mg tablet by mouth every 8 hours scheduled and a rescue prescription of oxycodone 5 mg tablets by mouth every 6 hours as needed for pain. Ten total oxycodone tablets will be prescribed.